AstraZeneca

AstraZeneca chief hints at changes with adverse outlook as patents expire

02 Feb 2013

AstraZeneca loses appeal on lung cancer drug rights in India

28 Nov 2012

AstraZeneca to pay Bristol-Myers Squibb $135 mn more for Amylin drug rights

10 Aug 2012

AstraZeneca will pay the $135 million to Bristol-Myers Squibb after the anti-trust and other competition regulators approve the acquisition of Amylin

Bristol-Myers Squibb, AstraZeneca expand alliance through Amylin acquisition

30 Jun 2012

AstraZeneca Q1 profit slumps; CEO quits

27 Apr 2012

AstraZeneca eliminates 7,300 jobs in major restructuring

03 Feb 2012

AstraZeneca's move to save $1.6 billion annually comes ahead of  the patent expiry of two of its top drugs over the next four years

AstraZeneca to buy China’s generic maker Guangdong BeiKang Pharma

08 Dec 2011

AstraZeneca to cut 1,150 sales jobs in the US

08 Dec 2011

AstraZeneca - Bristol-Myers to present new data on diabetes drug

27 Oct 2011

AstraZeneca close to selling dental implants unit to Dentsply for $1.8 billion: report

21 Jun 2011

Russia, China precede India for AstraZeneca's expansion plans

18 Jun 2011

AstraZeneca to pay $250,000 to 124 women for sex discrimination

07 Jun 2011

AstraZeneca, Daiichi Sankyo to promote Amgen's new bone cancer drug

24 May 2011

AstraZeneca saves over $1 billion in tax dispute settlement

28 Mar 2011

AstraZeneca to pay $198 million to settle 17,500 Seroquel lawsuits

09 Aug 2010

AstraZeneca scrip slumps after buy-back offer

07 Jul 2010

AstraZeneca settles US drug pricing suit for $103 million

19 Jun 2010

AstraZeneca settles Seroquel case with US government for $520 million

28 Apr 2010

AstraZeneca, Bristol-Myers Squibb in diabetes research alliance

01 Apr 2010

Torrent in AstraZeneca's debut deal to sell branded generics

11 Mar 2010

In its first ever deal with a generics manufacturer AstraZeneca will brand and sell Ahmedabad-based Torrent Pharma's generic drugs in emerging markets.

AstraZeneca settles UK tax dispute with £505 million payout

24 Feb 2010

AstraZeneca India to pay 500 per cent dividend

23 Feb 2010

AstraZeneca inks arthritis drug deal with Rigel

16 Feb 2010

US FDA approves AstraZeneca's Crestor

09 Feb 2010

AstraZeneca reports profit, cuts 8,000 jobs to cut costs

29 Jan 2010

Despite a $10.8 billion pre-tax profit,  the Anglo-Swedish pharma major is cutting 8,000 more jobs over the next four years to cope with revenue decline due to post-patent expiry competition from generic producers